Overview

Intravenous Exenatide in Patients With Acute Brain Injury

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the feasibility of exenatide infusion for the treatment of high blood sugars following acute brain injury.
Phase:
Phase 4
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
AstraZeneca
Medtronic
Treatments:
Exenatide